Press Releases

Date	Title
06/30/14	Summary Toggle Akebia Therapeutics Added to Russell 3000®, Russell 2000® and Russell Global Indexes	Akebia Therapeutics Added to Russell 3000®, Russell 2000® and Russell Global Indexes 15.8 KB
05/29/14	Summary Toggle Akebia Therapeutics Announces Upcoming Presentation at 51st ERA-EDTA Annual Congress	Akebia Therapeutics Announces Upcoming Presentation at 51st ERA-EDTA Annual Congress 22.3 KB
05/12/14	Summary Toggle Akebia to Present at the Annual UBS Global Healthcare Conference	Akebia to Present at the Annual UBS Global Healthcare Conference 64.2 KB
05/12/14	Summary Toggle Akebia Announces First Quarter 2014 Financial Results and Recent Corporate Highlights	Akebia Announces First Quarter 2014 Financial Results and Recent Corporate Highlights 64.2 KB
04/15/14	Summary Toggle Akebia Therapeutics Announces Completion of Enrollment in its Phase 2b Clinical Study of AKB-6548	Akebia Therapeutics Announces Completion of Enrollment in its Phase 2b Clinical Study of AKB-6548 69.9 KB
03/26/14	Summary Toggle Akebia Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares	Akebia Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares 66.5 KB
03/20/14	Summary Toggle Akebia Therapeutics Announces Pricing of Initial Public Offering	Akebia Therapeutics Announces Pricing of Initial Public Offering 65.2 KB
02/18/14	Summary Toggle Akebia Therapeutics Files Registration Statement for Proposed Initial Public Offering
02/18/14	Summary Toggle Akebia Therapeutics Appoints Michael Wyzga to its Board of Directors
01/10/14	Summary Toggle Akebia Therapeutics Strengthens Its Leadership Team with Key Additions